Terms: = Cervical cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43 AND Treatment
4 results:
1. Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the HSP90A/ndrg1 pathway.
Zheng P; Wu Y; Wang Y; Hu F
Cell Signal; 2023 Sep; 109():110771. PubMed ID: 37329997
[TBL] [Abstract] [Full Text] [Related]
2. A combined ANXA2-ndrg1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer.
Buttarelli M; Babini G; Raspaglio G; Filippetti F; Battaglia A; Ciucci A; Ferrandina G; Petrillo M; Marino C; Mancuso M; Saran A; Villani ME; Desiderio A; D'Ambrosio C; Scaloni A; Scambia G; Gallo D
J Exp Clin Cancer Res; 2019 Jun; 38(1):279. PubMed ID: 31242951
[TBL] [Abstract] [Full Text] [Related]
3. Radiation treatment planning using positron emission and computed tomography for lung and pharyngeal cancers: a multiple-threshold method for [(18)F]fluoro-2-deoxyglucose activity.
Okubo M; Nishimura Y; Nakamatsu K; Okumura M; Shibata T; Kanamori S; Hanaoka K; Hosono M
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):350-6. PubMed ID: 20457349
[TBL] [Abstract] [Full Text] [Related]
4. [Cf-252 neutron therapy of cervical carcinoma: topometrical radiotherapy planning using an afterloading technic and computerized tomography].
Merkle K; Spasokukotskaya ON
Arch Geschwulstforsch; 1986; 56(3):203-10. PubMed ID: 3729681
[TBL] [Abstract] [Full Text] [Related]
